Although a sense of complacency had perhaps developed since the initial peak in interest over agricultural animal biotechnologies during the early 1990s, recent developments in the eld since the turn of the century arguably expose the lack of regulatory preparedness vis-à-vis animal breeding technologies. Low public enthusiasm for the consumption of animals produced through such methods may still serve to scupper successful commercialization, but the lack of public involvement in the upstream innovation process and the ability of emergent regulatory regimes to narrow the question of oversight down to health and safety issues would seem to suggest that animals produced through GM and cloning may be with us shortly. In this sense regulations could be seen as enabling tools for capitalization, even if they should be an opportunity for meaningful democratic deliberation between science and the rest of society.